
Office of Communications
and Public Liaison (OCPL)
Building 31, Room 5C27
31 Center Drive, MSC 2292
Bethesda, MD 20892
Phone: 301-496-1752
nianews3@mail.nih.gov
America's elderly continue to defy negative stereotypes that aging is synonymous with increasing decline and disability. According to new findings from the National Long Term Care Surveys, disability rates among older people in the U.S. are...
Research on Alzheimer's disease is entering a new, highly productive phase and the pace of promising developments is accelerating, according to scientists at the National Institute on Aging (NIA). In an editorial examining important new findings...
In a 15-year study, anti-inflammatory drugs such as ibuprofen, taken for as little as two years, appear to reduce the risk of Alzheimer's Disease (AD). Acetaminophen, with no anti-inflammatory activity, had no effect on the risk of AD, while the...
A new study by researchers at the National Institute on Aging (NIA) demonstrates that a small number of diseases and conditions that can lead to hospitalization-- stroke, hip fracture, congestive heart failure, pneumonia, coronary heart disease,...
Repeated measures of the ratio of free to total prostate specific antigen (PSA) in a man's blood can predict a diagnosis of prostate cancer up to six years earlier than current prediction methods. This discovery by researchers at the National...
Now there's scientific proof that exercise can be a safe and effective treatment option for knee osteoarthritis - good news for the millions of disabled Americans suffering from this degenerative joint disease. A recent clinical study, funded by the...
The degree to which Cherokee Indians are of pure ancestry or mixed ancestry may play a role in delaying the development of Alzheimer's disease after age 65. Research by National Institute on Aging (NIA) grantees at the University of Texas...
A new mouse model that will further understanding of Alzheimer's disease and ultimately allow for testing of drug therapies has been developed by scientists at the University of Minnesota. The genetically-engineered mouse is the first to exhibit...
Several recent studies have begun to define the involvement of certain genes in the development of Alzheimer's disease. But a new study comparing the occurrence of dementia and Alzheimer's disease among different populations suggests there...
National Institute on Aging (NIA)-supported scientists at Columbia-Presbyterian Medical Center suggest that estrogen therapy taken by post-menopausal women may significantly delay the onset of Alzheimer's disease. Results of the study appear in...